Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-16 EDT 		5-day change 1st Jan Change
5.03 USD +2.24% Intraday chart for Moleculin Biotech, Inc. +5.23% -60.94%
05-15 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI
05-13 Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOLECULIN BIOTECH, INC.
Bio Therapeutic Drugs
+2.24%+5.23%-60.94%-45.12%-95.30% 11.2M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW